Biolog Recently Wins $2M in NIH Grants; Firm to Further Develop Phenotype Microrrary
Biolog has pocked approximately $2 million through four recent grants from the US National Institutes of Health, according to the NIH.
The company is developing living mammalian cell arrays for drug-discovery and -development applications. The four new grants, which the NIH said are effective as of Dec. 26, include:
• $920,940 for the detection of bioterrorism agents with [the company’s phenotype microarray] technology;